RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
PR Newswire —
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the "Class Period"), of the important April 14, 2026 lead plaintiff...